RhumbLine Advisers’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $301M | Sell |
611,950
-688
| -0.1% | -$373K | 0.26% | 59 |
|
|
2025
Q4 | $355M | Sell |
612,638
-11,564
| -2% | -$6.54M | 0.29% | 51 |
|
|
2025
Q3 | $303M | Sell |
624,202
-10,853
| -2% | -$5.05M | 0.24% | 61 |
|
|
2025
Q2 | $257M | Sell |
635,055
-23,302
| -4% | -$9.74M | 0.22% | 72 |
|
|
2025
Q1 | $328M | Sell |
658,357
-6,255
| -0.9% | -$3.39M | 0.31% | 46 |
|
|
2024
Q4 | $346M | Sell |
664,612
-10,559
| -2% | -$5.81M | 0.31% | 46 |
|
|
2024
Q3 | $418M | Sell |
675,171
-21,512
| -3% | -$12.7M | 0.38% | 37 |
|
|
2024
Q2 | $385M | Sell |
696,683
-16,283
| -2% | -$9.33M | 0.36% | 36 |
|
|
2024
Q1 | $414M | Buy |
712,966
+412
| +0.1% | +$231K | 0.4% | 35 |
|
|
2023
Q4 | $378M | Sell |
712,554
-3,810
| -0.5% | -$1.84M | 0.4% | 36 |
|
|
2023
Q3 | $363M | Buy |
716,364
+2,592
| +0.4% | +$1.38M | 0.42% | 34 |
|
|
2023
Q2 | $372M | Buy |
713,772
+14,229
| +2% | +$7.68M | 0.42% | 35 |
|
|
2023
Q1 | $403M | Buy |
699,543
+9,863
| +1% | +$5.56M | 0.5% | 29 |
|
|
2022
Q4 | $380M | Buy |
689,680
+30,462
| +5% | +$16.1M | 0.51% | 30 |
|
|
2022
Q3 | $334M | Buy |
659,218
+15,258
| +2% | +$8.54M | 0.5% | 28 |
|
|
2022
Q2 | $350M | Buy |
643,960
+30,674
| +5% | +$16.9M | 0.51% | 28 |
|
|
2022
Q1 | $362M | Buy |
613,286
+12,712
| +2% | +$7.3M | 0.47% | 32 |
|
|
2021
Q4 | $401M | Buy |
600,574
+5,105
| +0.9% | +$3.19M | 0.49% | 28 |
|
|
2021
Q3 | $340M | Sell |
595,469
-13,422
| -2% | -$7.37M | 0.46% | 32 |
|
|
2021
Q2 | $307M | Sell |
608,891
-31,721
| -5% | -$15M | 0.4% | 42 |
|
|
2021
Q1 | $292M | Sell |
640,612
-43,793
| -6% | -$20.9M | 0.4% | 43 |
|
|
2020
Q4 | $319M | Sell |
684,405
-6,331
| -0.9% | -$2.97M | 0.44% | 38 |
|
|
2020
Q3 | $305M | Buy |
690,736
+28,506
| +4% | +$11.8M | 0.48% | 36 |
|
|
2020
Q2 | $240M | Buy |
662,230
+29,799
| +5% | +$9.99M | 0.4% | 42 |
|
|
2020
Q1 | $179M | Buy |
632,431
+2,511
| +0.4% | +$792K | 0.38% | 50 |
|
|
2019
Q4 | $205M | Sell |
629,920
-1,202
| -0.2% | -$364K | 0.34% | 56 |
|
|
2019
Q3 | $184M | Buy |
631,122
+8,242
| +1% | +$2.36M | 0.34% | 55 |
|
|
2019
Q2 | $183M | Sell |
622,880
-11,308
| -2% | -$3.11M | 0.34% | 52 |
|
|
2019
Q1 | $174M | Sell |
634,188
-17,848
| -3% | -$4.44M | 0.34% | 60 |
|
|
2018
Q4 | $146M | Buy |
652,036
+7,916
| +1% | +$1.86M | 0.32% | 57 |
|
|
2018
Q3 | $157M | Sell |
644,120
-9,090
| -1% | -$2.09M | 0.3% | 63 |
|
|
2018
Q2 | $135M | Buy |
653,210
+19,282
| +3% | +$4.09M | 0.27% | 67 |
|
|
2018
Q1 | $131M | Sell |
633,928
-6,101
| -1% | -$1.28M | 0.27% | 67 |
|
|
2017
Q4 | $122M | Buy |
640,029
+21,515
| +3% | +$4.12M | 0.25% | 79 |
|
|
2017
Q3 | $117M | Buy |
618,514
+20,031
| +3% | +$3.63M | 0.25% | 76 |
|
|
2017
Q2 | $104M | Sell |
598,483
-4,787
| -0.8% | -$804K | 0.24% | 81 |
|
|
2017
Q1 | $92.7M | Sell |
603,270
-13,306
| -2% | -$2.03M | 0.22% | 89 |
|
|
2016
Q4 | $87M | Buy |
616,576
+23,809
| +4% | +$3.51M | 0.22% | 89 |
|
|
2016
Q3 | $94.3M | Buy |
592,767
+60,752
| +11% | +$9.36M | 0.26% | 73 |
|
|
2016
Q2 | $78.6M | Buy |
532,015
+19,813
| +4% | +$2.92M | 0.23% | 85 |
|
|
2016
Q1 | $72.5M | Buy |
512,202
+19,744
| +4% | +$2.65M | 0.23% | 89 |
|
|
2015
Q4 | $69.9M | Sell |
492,458
-2,130
| -0.4% | -$284K | 0.22% | 83 |
|
|
2015
Q3 | $60.5M | Sell |
494,588
-3,097
| -0.6% | -$403K | 0.21% | 91 |
|
|
2015
Q2 | $64.6M | Sell |
497,685
-87,102
| -15% | -$11.4M | 0.21% | 97 |
|
|
2015
Q1 | $78.6M | Sell |
584,787
-985
| -0.2% | -$127K | 0.23% | 95 |
|
|
2014
Q4 | $73.4M | Sell |
585,772
-10,558
| -2% | -$1.28M | 0.21% | 102 |
|
|
2014
Q3 | $72.6M | Sell |
596,330
-4,081
| -0.7% | -$496K | 0.22% | 102 |
|
|
2014
Q2 | $70.8M | Buy |
600,411
+25,088
| +4% | +$2.95M | 0.21% | 101 |
|
|
2014
Q1 | $69.2M | Buy |
575,323
+17,489
| +3% | +$2.08M | 0.21% | 103 |
|
|
2013
Q4 | $62.1M | Sell |
557,834
-24,059
| -4% | -$2.39M | 0.18% | 118 |
|
|
2013
Q3 | $53.6M | Sell |
581,893
-8,043
| -1% | -$727K | 0.17% | 130 |
|
|
2013
Q2 | $49.9M | Buy |
+589,936
| New | +$49.1M | 0.16% | 130 |
|
Other funds holding TMO
VCM
RhumbLine Advisers's TMO Position: Q1 2026 in Review
RhumbLine Advisers reduced its Thermo Fisher Scientific (TMO) stake by 0.11% in Q1 2026, selling an estimated $373K and leaving 611,950 shares worth $301M. The position accounts for 0.26% of the portfolio, ranked #59.
RhumbLine Advisers first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $418M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- RhumbLine Advisers held 611,950 shares of Thermo Fisher Scientific worth $301M as of Q1 2026.
- RhumbLine Advisers sold 688 Thermo Fisher Scientific shares in Q1 2026, an estimated $373K.
- Thermo Fisher Scientific made up 0.26% of RhumbLine Advisers's portfolio in Q1 2026, its #59 holding.
- RhumbLine Advisers first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- RhumbLine Advisers's Thermo Fisher Scientific position peaked at $418M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.